BioCentury | Dec 19, 2005
Strategy

Abgenix chronicles

...starts to submit a rolling BLA for panitumumab for colorectal cancerL. 6/29/01 - Partners with MDS Proteomics...
BioCentury | May 23, 2005
Finance

Ebb & Flow

...for a Canadian biotech. The cancer company slots in behind a $56.9 million round for MDS Proteomics...
BioCentury | Aug 3, 2004
Top Story

Cephalon meets Street

...earnings exclude a $30.1 million impairment charge associated with a write-off of its investment in MDS Proteomics...
BioCentury | Jun 7, 2004
Company News

MDS supply/service, proteomics news

...MDS subsidiary MDS Proteomics discontinued its drug discovery and development business to focus on providing services in...
...and development business to focus on providing services in biomarker identification, lead optimization and proteomics. MDS Proteomics...
...which will use them to develop assays for use in preclinical trials. MDS will pay MDS Proteomics...
BioCentury | Jan 20, 2003
Company News

MDS, Eli Lilly deal

...MDS subsidiary MDS Proteomics partnered with Eli Lilly Canada Inc. (Toronto, Ontario) to research the use of...
BioCentury | Jan 13, 2003
Company News

Cephalon, MDS deal

...CEPH will use MDS subsidiary MDS Proteomics Inc.’s differential analysis, chemiproteomics, PhosMap phosphorylation fingerprinting and protein interaction...
BioCentury | Jan 7, 2003
Company News

Cephalon, MDS Proteomics deal

...CEPH will use technology from MDS Proteomics , a subsidiary of MDS (TSE:MDS; MDZ), to aid in...
BioCentury | Mar 4, 2002
Company News

MDS Proteomics other research news

...whole cell lysate of S. cerevisiae, and led to the identification of 383 phosphorylation sites. MDS Proteomics...
BioCentury | Feb 25, 2002
Finance

Bells & whistles

...go cold, companies end up having to bail out the investors. That's what happened to MDS Proteomics...
...MDZ, Toronto, Ontario). Last April, MDS ended up buying back the special warrants sold by MDS Proteomics...
...of March, a promise made while the window was still open. Investors were fortunate that MDS Proteomics...
BioCentury | Feb 11, 2002
Company News

MDS Proteomics, Kazusa DNA Research Institute deal

...cDNA clones. MDS will use the clones for mapping disease pathways and determining protein function. MDS Proteomics...
Items per page:
1 - 10 of 39
BioCentury | Dec 19, 2005
Strategy

Abgenix chronicles

...starts to submit a rolling BLA for panitumumab for colorectal cancerL. 6/29/01 - Partners with MDS Proteomics...
BioCentury | May 23, 2005
Finance

Ebb & Flow

...for a Canadian biotech. The cancer company slots in behind a $56.9 million round for MDS Proteomics...
BioCentury | Aug 3, 2004
Top Story

Cephalon meets Street

...earnings exclude a $30.1 million impairment charge associated with a write-off of its investment in MDS Proteomics...
BioCentury | Jun 7, 2004
Company News

MDS supply/service, proteomics news

...MDS subsidiary MDS Proteomics discontinued its drug discovery and development business to focus on providing services in...
...and development business to focus on providing services in biomarker identification, lead optimization and proteomics. MDS Proteomics...
...which will use them to develop assays for use in preclinical trials. MDS will pay MDS Proteomics...
BioCentury | Jan 20, 2003
Company News

MDS, Eli Lilly deal

...MDS subsidiary MDS Proteomics partnered with Eli Lilly Canada Inc. (Toronto, Ontario) to research the use of...
BioCentury | Jan 13, 2003
Company News

Cephalon, MDS deal

...CEPH will use MDS subsidiary MDS Proteomics Inc.’s differential analysis, chemiproteomics, PhosMap phosphorylation fingerprinting and protein interaction...
BioCentury | Jan 7, 2003
Company News

Cephalon, MDS Proteomics deal

...CEPH will use technology from MDS Proteomics , a subsidiary of MDS (TSE:MDS; MDZ), to aid in...
BioCentury | Mar 4, 2002
Company News

MDS Proteomics other research news

...whole cell lysate of S. cerevisiae, and led to the identification of 383 phosphorylation sites. MDS Proteomics...
BioCentury | Feb 25, 2002
Finance

Bells & whistles

...go cold, companies end up having to bail out the investors. That's what happened to MDS Proteomics...
...MDZ, Toronto, Ontario). Last April, MDS ended up buying back the special warrants sold by MDS Proteomics...
...of March, a promise made while the window was still open. Investors were fortunate that MDS Proteomics...
BioCentury | Feb 11, 2002
Company News

MDS Proteomics, Kazusa DNA Research Institute deal

...cDNA clones. MDS will use the clones for mapping disease pathways and determining protein function. MDS Proteomics...
Items per page:
1 - 10 of 39